Not Signed In - Lipitor Significantly Reduced The Risk Of Serious Cardiovascular Events Compared With Simvastatin In An 80,000-Patient AnalysisManage
Sat, 03 Mar 2007 08:00 AM EST
... A retrospective analysis of a large U.S. managed care database showed that patients who took Pfizer's cholesterol-lowering medicine Lipitor(R) (atorvastatin calcium) Tablets had a significant 14 percent reduction in the risk of cardiovascular events, including heart attacks and strokes, compared with patients who took simvastatin. [click link for full article] ...
Related Topics
- Cardiovascular Diseases And Disorders
- Atorvastatin
- Simvastatin
- Risk Factors
- Cardiovascular Health
- Hypogammaglobulinemia (reduced levels of antibodies) -- increases the risk of infection
- Patient Issues
- Lovastatin
- Personal Medical Records
- Security Risk Assessment
- Cardiac Risk
- High Risk Pregnancy
- Theophylline Tablets or Capsules
- Theophylline Oral Solution, Syrup, or Suspension
- Youth Risk Behaviors
- Reduced intellect (sometimes)
- Reduced lung function
- Reduced communication skills (sometimes)
- Reduced life span
- Pravastatin
email this page
print this page
bookmark this page
feedback on this page
